BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹188 Cr | ₹156 Cr | ₹140 Cr | ₹78 Cr | ₹59 Cr |
What is the latest Net Current Assets ratio of BALAXI PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹188 Cr |
| Mar2024 | ₹156 Cr |
| Mar2023 | ₹140 Cr |
| Mar2022 | ₹78 Cr |
| Mar2021 | ₹59 Cr |
How is Net Current Assets of BALAXI PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹188 Cr | 20.68 | |
| Mar2024 | ₹156 Cr | 11.11 | |
| Mar2023 | ₹140 Cr | 80.59 | |
| Mar2022 | ₹78 Cr | 31.58 | |
| Mar2021 | ₹59 Cr | - | |
Compare Net Current Assets of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹127.1 Cr | -5.7% | -16.7% | -64.7% | Stock Analytics | |
| ADANI ENTERPRISES | ₹289,089.0 Cr | 15.2% | -1% | 0.4% | Stock Analytics | |
| REDINGTON | ₹20,892.9 Cr | 0.3% | -6.4% | 36.7% | Stock Analytics | |
| MMTC | ₹9,483.0 Cr | 0.3% | -5.4% | -6.3% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹9,466.2 Cr | 10.7% | -6.2% | 23.3% | Stock Analytics | |
| HONASA CONSUMER | ₹9,149.4 Cr | 1.4% | -6.3% | 25.8% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -5.7% |
-16.7% |
-64.7% |
| SENSEX | 1.3% |
-2.5% |
8.5% |
You may also like the below Video Courses